ORIGINAL ARTICLESDesign and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma
REFERENCES (25)
- et al.
Lack of correlations of symptoms with specialist-assessed long-term asthma severity
Chest.
(1999) - et al.
Distribution of IgE in a community population sample: correlations with age, sex, and allergen skin test reactivity
J Allergy Clin Immunol.
(1981) - et al.
Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease
J Allergy Clin Immunol.
(1980) - et al.
Surveillance for asthma—United States, 1960–1995
MMWR Morb Mortal Wkly Rep.
(1998) - et al.
Surveillance for asthma-United States, 1980–1999
MMWR Morb Mortal Wkly Rep.
(2002) Morbidity and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases
(2002)- et al.
Increasing U. S. asthma mortality rates: who is really dying?
J Asthma.
(2001) - et al.
Race and sex differences in consistency of care with national asthma guidelines in managed care organizations
Arch Intern Med.
(2001) - et al.
An economic evaluation of asthma in the United States
N Engl J Med.
(1992) - et al.
The costs of asthma
Eur Respir J.
(1996)
Impact of childhood asthma on health
Pediatrics.
(1992)
Association of asthma control with health care utilization
Am J Respir Crit Care Med.
(2002)
Cited by (274)
Changes in disease burden and treatment reality in patients with severe asthma
2024, Respiratory InvestigationReal-life studies and registries of severe asthma: The advent of digital technology
2023, Respiratory MedicineDevelopment and Dynamic Responsiveness of the Acute Asthma Exacerbation Survey in Patients With Moderate to Severe Disease
2023, Journal of Allergy and Clinical Immunology: In PracticeOmalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
2023, World Allergy Organization JournalMarkers of severity and predictors of response to treatment in severe asthma
2022, Revue des Maladies RespiratoiresPrevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan
2020, Allergology International
The TENOR study is sponsored by Genentech Inc and Novartis Pharmaceuticals Corp.
Copyright © 2004 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.